Palo Alto, California, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced that its management will be participating in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9 and 10, 2025. Oren Elkayam, the Company’s Founder and CEO, will deliver a presentation at 3:00 PM ET on Tuesday, December 9, followed by one-on-one meetings with in ...

SLINGERLANDS, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in two upcoming investor conferences this week in New York, New York, reinforcing its commitment to ongoing engagement with the financial community. Plug executives, Paul Middleton, CFO and Roberto Friedlander, VP of Investor Relations, will participate in one-on-one meetings with institutional investors to discuss the ...

As previously announced, low dose D-cycloserine has been associated with augmentation of the antidepressant and antisuicidal response achieved by Transcranial Magnetic Stimulation (TMS).NRx has amended its Investigational New Drug filing for NRX-101 (D-cycloserine/lurasidone) to include its use in association with TMS for the treatment of depression, including suicidal depression. This protocol will be available to patients both through a clinical trial and under NRx’s Expanded Access protocols.NRx currentl ...

Advances electrification of calcination furnaces in the cement industry using plasma torch technologyMONTREAL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces that it has signed a EUR815,000 (CAD$1,324,000) contract with a European cement industry customer for the supply of a plasma torch system for ...

Event Sponsored by BioXcel Therapeutics Set for 10 a.m. EST on Monday, Dec. 8 Topics Covered by Drs. Leslie Citrome, Marc Milano, and Leon Ravin to Include Opportunities and Advantages of Self-Administered Treatments at Home NEW HAVEN, Conn., Dec. 03, 2025 (GLOBE NEWSWIRE) -- As millions of patients and caregivers continue to struggle with acute agitation episodes associated with bipolar disorder and schizophrenia, a timely and highly anticipated virtual roundtable will bring together leading medical exper ...

CAMARILLO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Newton Golf Company (NASDAQ: NWTG), a leader in physics-based golf shaft technology, today announced that the Company achieved its highest single-day sales total in history on Black Friday, driven by continued demand for the Fast Motion and Motion shaft families. The Company also confirmed that November 2025 is the strongest November sales month in Newton’s history. Black Friday generated the largest number of direct-to-consumer orders the Compa ...

The final event brings back the bestsellers by popular demand from Dec 2nd – Dec 7thSACRAMENTO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- After a record-smashing Black Friday, HTVRONT, the global innovator in heat press and crafting technology, is keeping the excitement alive, extending its Black Friday deals for six more days (Dec 2nd to Dec 7th) on the official website and Amazon store — offering one last chance to grab handy and innovative machines and materials at the year's lowest prices. "The Black F ...

Making HPV Tests & Quality Assessment Products Available across MexicoMISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Seegene Mexico S.A.P.I. de C.V. (Seegene Mexico), a firm focused upon transforming molecular diagnostics with innovative multiplex solutions, announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the ...

EVgo Autocharge+ EVgo has surpassed five million Autocharge+ sessions. More than 300,000 customer accounts have enrolled over the last three years, representing a sixfold growth since 2022. LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- EVgo Inc. (NASDAQ: EVGO) (“EVgo” or the “Company”), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), has surpassed five million Autocharge+ sessions. EVgo has had sixfold growth in enrollment since 2023, with over ...

Core Viewpoint - BioCryst Pharmaceuticals has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its proposed acquisition of Astria Therapeutics, indicating progress towards the merger [1][2]. Group 1: Merger Details - The termination of the waiting period satisfies one of the conditions for the merger, with BioCryst expecting the merger to close in the first quarter of 2026, pending other customary closing conditions [2]. - BioCryst has filed a registration statement with the SEC, which includes a preliminary proxy statement of Astria and a preliminary prospectus of BioCryst regarding the merger [5][6]. Group 2: Company Overview - BioCryst Pharmaceuticals is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema and other rare diseases, with a commitment to improving the lives of affected individuals [3]. - The company has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for various rare diseases [3].